An intercomparison between film dosimetry and diode matrix for IMRT quality assurance.

The evaluation of the agreement between measured and calculated dose plays an essential role in the quality assurance (QA) procedures for intensity modulated radiation therapy (IMRT). Film dosimetry has been widely adopted for this purpose due to excellent film characteristics in terms of spatial resolution; unfortunately, it is a time-consuming procedure and requires great care if film has to be used as an absolute dosimeter. If this is not the case, then an independent ionimetric measurement is mandatory to assess the absolute dose agreement. Arrays of detectors are now replacing films for routine IMRT QA, since they permit very simple verification procedures. They show excellent characteristics in terms of linearity, repeatability, and independence of the response from the dose rate, but at the same time present a poor spatial resolution, due to the limited number of detectors available. In our institution, a diode matrix (MapCHECK, provided by Sun Nuclear) is adopted for routine QA. The aim of this work is to compare the performances of absolute film dosimetry with this matrix in QA procedures and to investigate the origin of possible discrepancies between the two methods. The results we present show a very good agreement between the two detectors when used to assess the mean dose deviation between calculated and measured doses (in both cases 0.2%). If the y matrix method is adopted, MapCHECK response shows a slightly better agreement with computed dose distribution than film dosimetry (mean percentage of points satisfying the constraint y < or = 1: 96% versus 94%). This difference is shown not to depend on the different field sampling, but on the detectors' capabilities. Moreover, we show that the diode matrix is able to identify eventual delivery errors as well as film. Our conclusion is that the diode matrix may effectively replace both film dosimetry and ionimetric measurements in routine IMRT QA.

Pretreatment verification of IMRT absolute dose distributions using a commercial a-Si EPID.

A commercial amorphous silicon electronic portal imaging device (EPID) has been studied to investigate its potential in the field of pretreatment verifications of step and shoot, intensity modulated radiation therapy (IMRT), 6 MV photon beams. The EPID was calibrated to measure absolute exit dose in a water-equivalent phantom at patient level, following an experimental approach, which does not require sophisticated calculation algorithms. The procedure presented was specifically intended to replace the time-consuming in-phantom film dosimetry. The dosimetric response was characterized on the central axis in terms of stability, linearity, and pulse repetition frequency dependence. The a-Si EPID demonstrated a good linearity with dose (within 2% from 1 monitor unit), which represent a prerequisite for the application in IMRT. A series of measurements, in which phantom thickness, air gap between the phantom and the EPID, field size and position of measurement of dose in the phantom (entrance or exit) varied, was performed to find the optimal calibration conditions, for which the field size dependence is minimized. In these conditions (20 cm phantom thickness, 56 cm air gap, exit dose measured at the isocenter), the introduction of a filter for the low-energy scattered radiation allowed us to define a universal calibration factor, independent of field size. The off-axis extension of the dose calibration was performed by applying a radial correction for the beam profile, distorted due to the standard flood field calibration of the device. For the acquisition of IMRT fields, it was necessary to employ home-made software and a specific procedure. This method was applied for the measurement of the dose distributions for 15 clinical IMRT fields. The agreement between the dose distributions, quantified by the gamma index, was found, on average, in 97.6% and 98.3% of the analyzed points for EPID versus TPS and for EPID versus FILM, respectively, thus suggesting a great potential of this EPID for IMRT dosimetric applications.

Improvements in CVD diamond properties for radiotherapy dosimetry.

The goal of this work was to compare the behaviour of a chemical vapour deposited (CVD) diamond sample, grown at the University of Florence using a local procedure, with that of a commercial CVD diamond. The comparison was performed exposing both systems to 25 MV photons and measuring the current response during irradiation. Properties of dosimetric interest such as stability of response, dose rate dependence and rise time were investigated. After a preliminary study, which evidenced better performances of the commercial device with respect to the local CVD diamond, the latter was irradiated with a high fluence of fast neutrons. As a result of the neutron treatment, the quality of the CVD home-made diamond has been improved to match with that of the commercial dosemeter.

Role of portal imaging in clinical radiotherapy: Florence experience.

A portal imaging device developed at the Netherlands' Cancer Institute (NKI) in Amsterdam was provided to the Radiotherapy Section of the University of Florence as a partner of a cooperative study on quality assurance (QUIRT) granted by the EC (AIM Project). The device was used for portal imaging in 30 patients treated for tumors of different sites (5 rectum, 6 prostate, 5 Hodgkin's lymphomas, 5 head and neck tumors, 9 other sites). Portal images were obtained three times per week over the whole treatment period. An off-line quantitative analysis of discrepancies with respect to the simulation image was performed for the 5 rectum cases; a similar analysis was also done on the portal images of 4 rectal cases treated at the NKI in Amsterdam. The analysis proved capable of demonstrating the existence of some systematic errors in both centres and the different level of global accuracy between them. The on-line use of the device was also able to demonstrate some major errors of patient setup during the first session, which were immediately corrected.

Magnetic resonance imaging of blood flow in thoracic vessels of patients with impaired left ventricular function.

In order to test the ability of magnetic resonance (MR) in the detection of pathologic flow conditions in man, we imaged 10 normal volunteers and 10 patients with congestive heart failure (CHF) with ECG-gated MR. We used a single spin-echo sequence on a transverse plane through the main vessels of the upper chest. The analysis of the variation of the mean signal intensity vs time from the ascending aorta (AA), descending aorta (DA), and pulmonary artery (PA) of the ten normal volunteers on the TE = 30 ms images, showed a common pattern characterized by an end-diastolic intraluminal signal not present in other moments of the cardiac cycle. On the contrary, in patients with CHF, we did not observe the systolic disappearance of the intraluminal MR signal. The main difference between CHF patients and control subjects was found in the DA where an abnormally high signal intensity was present for the whole cardiac cycle. The MR imaging can offer blood flow information underlying the behavior of intraluminal signal intensity and could provide functional information in patients with heart failure.

Fast multiphase MR imaging of aqueductal CSF flow: 1. Study of healthy subjects.

Gradient-echo MR sequences are more sensitive to flow phenomena than spin-echo sequences are. We investigated aqueductal CSF flow by fast multiphase imaging. Fast multiphase imaging offers the opportunity to perform a dynamic study of fluid motion that is synchronous with the cardiac cycle. A section perpendicular to the cerebral aqueduct was imaged in 18 healthy volunteers. Serial, gated (every 50 msec from the ECG R wave), flow-compensated modulus images with 70 degrees-flip-angle excitation pulses were obtained with a single acquisition. The behavior vs time of CSF signal in the aqueduct was compared with that in the lateral ventricles. The former showed a peak at 0.47 +/- 0.1 fractions of a heart cycle after the R wave. No periodicity with the heart rate was observed for the ventricular CSF signal intensity. The mean CSF signal intensity in the aqueduct was found to range from about twice to three times that in the lateral ventricles over a cardiac cycle. Fast multiphase imaging is a sensitive and practical sequence for the MR investigation of aqueductal CSF flow. Its potential in patients with hydrocephalus is studied in a companion article.

Fast multiphase MR imaging of aqueductal CSF flow: 2. Study in patients with hydrocephalus.

The signal intensity in the region corresponding to the cerebral aqueduct was evaluated in three patients with noncommunicating tension hydrocephalus (caused by aqueductal obstruction in two and type I Arnold-Chiari malformation in the other), seven patients with suspected normal-pressure hydrocephalus (three of whom subsequently underwent successful shunting), and 10 patients with ex vacuo (atrophic) hydrocephalus. A gradient-echo MR sequence, called fast multiphase imaging, was used. Serial images corresponding to different phases of the cardiac cycle were acquired. No flow-related enhancement was observed over the entire cardiac cycle in the patients with noncommunicating hydrocephalus. Patients with normal-pressure hydrocephalus showed a higher aqueductal CSF signal intensity, consistent with increased systolic flow rates, than patients with ex vacuo hydrocephalus. When comparing the above two groups of patients with a control group of healthy volunteers, significantly higher and lower values of the (mean) maximum aqueductal signal intensity were found in the normal-pressure hydrocephalus patients and the ex vacuo hydrocephalus patients, respectively. Fast multiphase MR evaluation of aqueductal CSF flow may help to differentiate patients with different types of hydrocephalus.

Relaxation rates of paramagnetic solutions: evaluation by nuclear magnetic resonance imaging.

Methods for accurate calculation of nuclear magnetic resonance relaxation times are presented. Data from inversion recovery sequences with different delay times were fitted to derive T1 information on water solutions of paramagnetic ions. T2 values of the same samples were obtained by fitting signals from a multiecho sequence. According to the theory, for the field strength used (0.5 T), T1's and T2's are nearly equal and the enhancement of relaxation rates is found to be directly proportional to molar concentration. Tests performed suggest the opportunity of using the same approach in studies of tissues.

Dosimetric characterization of a bi-directional micromultileaf collimator for stereotactic applications.

A 6 MV photon beam from Linac SL75-5 has been collimated with a new micromultileaf device that is able to shape the field in the two orthogonal directions with four banks of leaves. This is the first clinical installation of the collimator and in this paper the dosimetric characterization of the system is reported. The dosimetric parameters required by the treatment planning system used for the dose calculation in the patient are: tissue maximum ratios, output factors, transmission and leakage of the leaves, penumbra values. Ionization chambers, silicon diode, radiographic films, and LiF thermoluminescent dosimeters have been employed for measurements of absolute dose and beam dosimetric data. Measurements with different dosimeters supply results in reasonable agreement among them and consistent with data available in literature for other models of micromultileaf collimator; that permits the use of the measured parameters for clinical applications. The discrepancies between results obtained with the different detectors (around 2%) for the analyzed parameters can be considered an indication of the accuracy that can be reached by current stereotactic dosimetry.

Diamond detector versus silicon diode and ion chamber in photon beams of different energy and field size.

The aim of this work was to test the suitability of a PTW diamond detector for nonreference condition dosimetry in photon beams of different energy (6 and 25 MV) and field size (from 2.6 cm x 2.6 cm to 10 cm x 10 cm). Diamond behavior was compared to that of a Scanditronix p-type silicon diode and a Scanditronix RK ionization chamber. Measurements included output factors (OF). percentage depth doses (PDD) and dose profiles. OFs measured with diamond detector agreed within 1% with those measured with diode and RK chamber. Only at 25 MV, for the smallest field size, RK chamber underestimated OFs due to averaging effects in a pointed shaped beam profile. Agreement was found between PDDs measured with diamond detector and RK chamber for both 6 MV and 25 MV photons and down to 5 cm x 5 cm field size. For the 2.6 cm x 2.6 cm field size, at 25 MV, RK chamber underestimated doses at shallow depth and the difference progressively went to zero in the distal region. PDD curves measured with silicon diode and diamond detector agreed well for the 25 MV beam at all the field sizes. Conversely, the nontissue equivalence of silicon led, for the 6 MV beam, to a slight overestimation of the diode doses in the distal region, at all the field sizes. Penumbra and field width measurements gave values in agreement for all the detectors but with a systematic overestimate by RK measurements. The results obtained confirm that ion chamber is not a suitable detector when high spatial resolution is required. On the other hand, the small differences in the studied parameters, between diamond and silicon systems, do not lead to a significant advantage in the use of diamond detector for routine clinical dosimetry.

An investigation of the operating characteristics of two PTW diamond detectors in photon and electron beams.

The dosimetric properties of two PTW Riga diamond detectors type 60003 were studied in high-energy photon and electron therapy beam. Properties under study were current-voltage characteristic, polarization effect, time stability of response, dose response, dose-rate dependence, temperature stability, and beam quality dependence of the sensitivity factor. Differences were shown between the two detectors for most of the previous properties. Also, the observed behavior was, to some extent, different from what was reported in the PTW technical specifications. The necessity to characterize each diamond detector individually was addressed.

A pencil beam algorithm for proton dose calculations.

The sharp lateral penumbra and the rapid fall-off of dose at the end of range of a proton beam are among the major advantages of proton radiation therapy. These beam characteristics depend on the position and characteristics of upstream beam-modifying devices such as apertures and compensating boluses. The extent of separation, if any, between these beam-modifying devices and the patient is particularly critical in this respect. We have developed a pencil beam algorithm for proton dose calculations which takes accurate account of the effects of materials upstream of the patient and of the air gap between them and the patient. The model includes a new approach to picking the locations of the pencil beams so as to more accurately model the penumbra and to more effectively account for the multiple-scattering effects of the media around the point of interest. We also present a faster broad-beam version of the algorithm which gives a reasonably accurate penumbra. Predictions of the algorithm and results from experiments performed in a large-field proton beam are presented. In general the algorithm agrees well with the measurements.

Neuronavigation accuracy dependence on CT and MR imaging parameters: a phantom-based study.

Clinical benefits from neuronavigation are well established. However, the complexity of its technical environment requires a careful evaluation of different types of errors. In this work, a detailed phantom study which investigates the accuracy in a neuronavigation procedure is presented. The dependence on many different imaging parameters, such as field of view, slice thickness and different kind of sequences (sequential and spiral for CT, T1-weighted and T2-weighted for MRI), is quantified. Moreover, data based on CT images are compared to those based on MR images, taking into account MRI distortion. Finally, the contributions to global accuracy coming from image acquisition, registration and navigation itself are discussed. Results demonstrate the importance of imaging accuracy. Procedures based on CT proved to be more accurate than procedures based on MRI. In the former, values from 2 to 2.5 mm are obtained for 95% fractiles of cumulative distribution of Euclidean distances between the intended target and the reached one while, in the latter, the measured values range from 3 to 4 mm. The absence of imaging distortion proved to be crucial for registration accuracy in MR-based procedures.

Quantitative magnetic resonance imaging in cervical carcinoma: a report on 30 cases.

T1 and T2 relaxation times were calculated, before radiation therapy, in 30 patients with cervical carcinoma. Eight healthy young women were submitted to magnetic resonance imaging (MRI) to determine T1 and T2 times of the normal cervix. Magnetic resonance imaging was repeated, in 22 patients, during radiation therapy and at follow-up. During treatment and follow-up, patients with complete tumour response showed a significant T1 reduction compared with the pre-treatment values. With persistence of palpable or visible tumour, T1 times showed a small decrease during therapy, and a marked increase at subsequent examinations. The results suggest that the modifications of T1 times, during radiation therapy and follow-up, could be considered as a useful discriminant between patients with differing tumour response.

The use of thermoluminescent detectors for measurements of proton dose distribution.

The aim of this work was to investigate the use of TLD-100 detectors in the field of relative dosimetry in proton eye facilities. These dosemeters, of different sizes, were used to measure transverse and longitudinal distributions of 62 MeV unmodulated proton beams at INFN-LNS in Catania. Comparison with other detectors, such as ionisation chambers, GAF and radiographic film, is extensively discussed.

Role of radiotherapy boost in women with ductal carcinoma in situ: a single-center experience in a series of 389 patients.

BACKGROUND: The use of adjuvant radiotherapy in ductal carcinoma in situ is accepted by most radiation oncologists worldwide; the role of a boost on the tumor bed is however more controversial. MATERIALS AND METHODS: We reviewed our Institute experience in DCIS treatment, focusing on main prognostic factors and impact of radiation boost on local relapse. A total of 389 patients treated between 1990 and 2007 were retrospectively analyzed. All patients received adjuvant radiotherapy after breast-conserving surgery for a median dose of 50 Gy; 190 patients (48.8%) received and additional radiation boost on the tumor bed. RESULTS: At a mean follow up of 7.7 years, we recorded 26 local recurrence (6.7%). Concerning local relapse-free survival, at Cox regression univariate analyses <1 mm surgical margins (p < 0.0001) and young age (p = 0.01) emerged as significant unfavorable prognostic factors. At multivariate analysis Cox regression model, surgical margins (p < 0.001) and radiation boost (p = 0.014) resulted as the significant independent predictors of recurrence. CONCLUSIONS: Our experience showed the negative prognostic impact of surgical margins <1 mm and the protective role of radiation boost on LR rate. Anyway, results from ongoing prospective Phase III studies are strongly necessary to better identify high-risk DCIS patients.